COVID-19

An expert review by an international group of scientists concluded that, even for the delta variant, vaccine efficacy against severe novel

University of Arizona researchers Esther Sternberg, MD, and Altaf Engineer, MS, have come up with a roadmap to help companies rethink their office

A new study by Mayo Clinic investigators highlights the development and implementation of the healthcare organization’s large-scale COVID-19

People who tested positive for SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19),  after one or two vaccine doses had

After years of steady reductions in healthcare-associated infections, significantly higher rates of four out of six routinely tracked infections were

Novel coronavirus (COVID-19) vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their

People infected with the SARS-CoV-2 delta variant have approximately double the risk of hospitalization compared with those infected with the alpha

The U.S. Centers for Disease Control and Prevention (CDC) may have increased the threat of novel coronavirus (COVID-19) infection in the Black